Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant-Reference-Cited by-同舟云学术

Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant

Published:2024-04-02 Issue:1 Volume:23 Page:432-444
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Pastore Gabiria¹,Polvere Jacopo¹,Fiorino Fabio¹²,Lucchesi Simone¹,Montesi Giorgio¹,Rancan Ilaria³⁴,Zirpoli Sara¹,Lippi Arianna³⁴,Durante Miriam³,Fabbiani Massimiliano³,Tumbarello Mario³⁴,Montagnani Francesca³⁴,Medaglini Donata¹,Ciabattini Annalisa¹

Affiliation:

1. Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy

2. Department of Medicine and Surgery, LUM University “Giuseppe Degennaro”; Casamassima, Bari, Italy

3. Department of Medical Biotechnologies, University of Siena, Siena, Italy

4. Department of Medical Sciences, Infectious and Tropical Diseases Unit, University Hospital of Siena, Siena, Italy

Funder

European Union-Next Generation EU

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2024.2333952

Reference72 articles.